Literature DB >> 429569

Resting skeletal muscle membrane potential as an index of uremic toxicity. A proposed new method to assess adequacy of hemodialysis.

J R Cotton, T Woodard, N W Carter, J P Knochel.   

Abstract

Electrochemical disturbances of skeletal muscle cells in untreated uremia are characterized by an increase in the intracellular sodium and chloride content, a decrease in intracellular potassium, and a low resting membrane potential. In this study, we have reexamined the foregoing and, in addition, have examined the effects of hemodialysis. Three groups of patients were studied. In the first group of 22 uncomplicated uremic patients, whose creatinine clearance (Ccr) ranged from 2 to 12 cm(3)/min per 1.73 m(2), resting transmembrane potential difference (Em) of skeletal muscle cells was measured. In each of the nine patients whose Ccr ranged between 6.3 and 12 cm(3)/min, the Em was normal (i.e., -90.8+/-0.9 mV, mean+/-SEM). However, as Ccr dropped below 6.3 cm/min, the Em became progressively reduced and assumed a linear relationship with the Ccr. In the second study, nine individuals with end-stage renal disease, whose mean Ccr was 4.3 cm(3)/min, underwent measurement of Em and intracellular electrolyte concentration before and after 7 wk of hemodialysis. Before dialysis, the Em was -78.5+/-2.1 mV, intracellular sodium and chloride were elevated, and the intracellular potassium was reduced. After 7 wk of hemodialysis the Em rose to -87.8+/-1.3 mV, and the intracellular sodium, chloride, and potassium became normal. In the third study, seven patients who were stable on 6-h thrice-weekly dialysis were studied before and after reduction of dialysis to 6 h twice weekly. In those individuals whose Em remained normal after 6 wk, dialysis time was reduced further. On thrice-weekly dialysis the Em was -91.2+/-1.0 mV. With reduced dialysis, the Em fell to -80.1+/-0.8 mV (P < 0.001). In each case, the Em became abnormal before significant signs or symptoms of uremia were noted. These findings demonstrate that end-stage renal disease is associated with serious electrochemical changes in the muscle cell which are reversed by hemodialysis and recur when dialysis time is reduced. Thus, serial observations of muscle Em may be a potentially powerful tool to assess adequacy of dialysis therapy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 429569      PMCID: PMC371979          DOI: 10.1172/JCI109328

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  4 in total

1.  Decreased ouabain-sensitive adenosine triphosphatase activity in the erythrocyte membrame of patients with chronic renal disease.

Authors:  C H Cole
Journal:  Clin Sci Mol Med       Date:  1973-12

2.  Cell sodium, potassium and water in uraemia and the effects of regular dialysis as studied in the leucocyte.

Authors:  J Patrick; N F Jones
Journal:  Clin Sci Mol Med       Date:  1974-05

3.  Potassium deficiency in chronic renal failure.

Authors:  G L Bilbrey; N W Carter; M G White; J F Schilling; J P Knochel
Journal:  Kidney Int       Date:  1973-12       Impact factor: 10.612

4.  Functional and metabolic studies on red blood cell sodium transport in chronic uremia.

Authors:  H J Kramer; D Gospodinov; F Krück
Journal:  Nephron       Date:  1976       Impact factor: 2.847

  4 in total
  11 in total

Review 1.  Abnormalities of serum potassium concentration in dialysis-associated hyperglycemia and their correction with insulin: a unique clinical/physiologic exercise in internal potassium balance.

Authors:  Antonios H Tzamaloukas; Todd S Ing; Moses S Elisaf; Dominic S C Raj; Kostas C Siamopoulos; Mark Rohrscheib; Glen H Murata
Journal:  Int Urol Nephrol       Date:  2010-09-19       Impact factor: 2.370

2.  Muscle cell electrical hyperpolarization and reduced exercise hyperkalemia in physically conditioned dogs.

Authors:  J P Knochel; J D Blachley; J H Johnson; N W Carter
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

3.  Erythrocyte Na,K pump in uremia. Acute correction of a transport defect by hemodialysis.

Authors:  H Izumo; S Izumo; M DeLuise; J S Flier
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

4.  Mechanism of alteration of sodium potassium pump of erythrocytes from patients with chronic renal failure.

Authors:  J T Cheng; T Kahn; D M Kaji
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

5.  Abnormal sodium transport in synaptosomes from brain of uremic rats.

Authors:  C L Fraser; P Sarnacki; A I Arieff
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

6.  Abnormal cation transport in uremia. Mechanisms in adipocytes and skeletal muscle from uremic rats.

Authors:  W Druml; R A Kelly; R C May; W E Mitch
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

7.  Erythrocyte sodium transport in dialyzed uremic patients.

Authors:  Y S Yoon; S Y Kim; W S Koo; E J Choi; Y S Chang; B K Bang; H R Moon
Journal:  Korean J Intern Med       Date:  1989-01       Impact factor: 2.884

8.  Factors associated with Hypokalemia in Continuous Ambulatory Peritoneal Dialysis Patients.

Authors:  Hyun-Wook Kim; Jae Hyun Chang; Sun Young Park; Sung Jin Moon; Dong Ki Kim; Jung Eun Lee; Seung Hyeok Han; Beum Seok Kim; Shin-Wook Kang; Kyu Hun Choi; Ho Young Lee; Dae-Suk Han
Journal:  Electrolyte Blood Press       Date:  2007-12-31

Review 9.  Human atrial cell models to analyse haemodialysis-related effects on cardiac electrophysiology: work in progress.

Authors:  Elisa Passini; Simonetta Genovesi; Stefano Severi
Journal:  Comput Math Methods Med       Date:  2014-12-23       Impact factor: 2.238

Review 10.  Fluid balance concepts in medicine: Principles and practice.

Authors:  Maria-Eleni Roumelioti; Robert H Glew; Zeid J Khitan; Helbert Rondon-Berrios; Christos P Argyropoulos; Deepak Malhotra; Dominic S Raj; Emmanuel I Agaba; Mark Rohrscheib; Glen H Murata; Joseph I Shapiro; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2018-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.